The underlying mechanism involves cancer immune evasion via transforming growth factor beta-1 (TGF-β1) secretion by LARS B cells, driven by leucine-stimulated mitochondrial NAD+ regeneration and oxidative metabolism [76]. This evidence concerns the gene TGFB1 and cancer.